Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CHGA
12526
Change Agents Corp
CHGA
$2.81M
| $29.8K | ﹤0.01% |
+2,809
| New | +$46.6K |
2026 Q1
0 quarters
|
|
|
ORGN
12527
DELISTED
Origin Materials
ORGN
| $29.8K | ﹤0.01% |
13,055
-31,525
| -71% | -$155K |
2020 Q4
21 quarters
|
|
12528
CALL
Century Therapeutics
IPSC
$277M
| $29.6K | ﹤0.01% |
+13,100
| New | +$27.5K |
2026 Q1
0 quarters
|
|
12529
CALL
Natural Health Trends
NHTC
$8.58M
| $29.6K | ﹤0.01% |
+10,600
| New | +$35.4K |
2026 Q1
0 quarters
|
|
12530
PUT
Lufax Holding
LU
$884M
| $29.5K | ﹤0.01% |
15,800
-9,400
| -37% | -$23.7K |
2020 Q4
21 quarters
|
|
12531
AquaBounty Technologies
AQB
$4.76M
| $29.4K | ﹤0.01% |
34,028
-559
| -2% | -$521 |
2025 Q4
1 quarter
|
|
12532
CALL
Leslie's
LESL
$1.36M
| $29.3K | ﹤0.01% |
26,200
+6,135
| +31% | +$7.89K |
2025 Q4
1 quarter
|
|
|
RCT
12533
RedCloud Holdings
RCT
$14.6M
| $29.1K | ﹤0.01% |
41,199
-12,505
| -23% | -$13.2K |
2025 Q4
1 quarter
|
|
|
SQNS
12534
PUT
Sequans Communications SA
SQNS
$42M
| $28.8K | ﹤0.01% |
11,400
-12,070
| -51% | -$45.8K |
2025 Q3
2 quarters
|
|
|
YRD
12535
PUT
Yiren Digital
YRD
$83.7M
| $28.7K | ﹤0.01% |
16,700
-7,000
| -30% | -$24.9K |
2022 Q4
13 quarters
|
|
12536
PUT
GrowGeneration
GRWG
$92.5M
| $28.7K | ﹤0.01% |
26,100
-11,400
| -30% | -$14.2K |
2020 Q3
22 quarters
|
|
|
BMNG
12537
PUT
Leverage Shares 2X Long BMNR Daily ETF
BMNG
$65.3M
| $28.7K | ﹤0.01% |
1,185
+380
| +47% | +$16.5K |
2025 Q4
1 quarter
|
|
12538
CALL
Zevia
ZVIA
$87.3M
| $28.7K | ﹤0.01% |
24,500
+700
| +3% | +$1.11K |
2025 Q4
1 quarter
|
|
|
HEPS
12539
CALL
D-Market Electronic Services & Trading
HEPS
$872M
| $28.6K | ﹤0.01% |
10,900
-2,600
| -19% | -$7.1K |
2025 Q4
1 quarter
|
|
12540
PUT
Conduent
CNDT
$257M
| $28.5K | ﹤0.01% |
22,300
-3,200
| -13% | -$4.88K |
2024 Q2
7 quarters
|
|
12541
CALL
Arq
ARQ
$84.7M
| $28.4K | ﹤0.01% |
+11,100
| New | +$35.6K |
2026 Q1
0 quarters
|
|
12542
PUT
Acumen Pharmaceuticals
ABOS
$148M
| $28.3K | ﹤0.01% |
+12,000
| New | +$30.6K |
2026 Q1
0 quarters
|
|
12543
CALL
Gain Therapeutics
GANX
$74.6M
| $28.1K | ﹤0.01% |
14,500
-36,900
| -72% | -$80.3K |
2025 Q3
2 quarters
|
|
|
VIVO
12544
PUT
VivoPower PLC
VIVO
$107M
| $28.1K | ﹤0.01% |
12,200
-14,500
| -54% | -$32.3K |
2025 Q3
2 quarters
|
|
12545
CALL
PSQ Holdings
PSQH
$17.5M
| $28K | ﹤0.01% |
3,527
-21,053
| -86% | -$250K |
2024 Q4
5 quarters
|
|
|
KRSA
12546
Korsana Biosciences, Inc. Common Stock
KRSA
$1.39B
| $28K | ﹤0.01% |
+2,609
| New | +$26K |
2026 Q1
0 quarters
|
|
12547
PUT
AC Immune
ACIU
$271M
| $27.8K | ﹤0.01% |
10,100
-1,300
| -11% | -$4.04K |
2025 Q1
4 quarters
|
|
12548
CALL
Kaltura
KLTR
$200M
| $27.7K | ﹤0.01% |
+22,700
| New | +$32.3K |
2026 Q1
0 quarters
|
|
12549
CALL
Heron Therapeutics
HRTX
$66M
| $27.7K | ﹤0.01% |
34,600
+17,200
| +99% | +$19.9K |
2025 Q4
1 quarter
|
|
|
NAKA
12550
PUT
Nakamoto Inc
NAKA
$173M
| $27.6K | ﹤0.01% |
3,128
-14,660
| -82% | -$186K |
2025 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.